blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4225338

EP4225338 - ENGINEERED PROBIOTICS FOR EXPRESSION OF FIBER-SYNTHESIZING ENZYMES IN GUT [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  14.07.2023
Database last updated on 06.07.2024
FormerThe international publication has been made
Status updated on  16.04.2022
Most recent event   Tooltip15.12.2023Change: Validation statespublished on 17.01.2024  [2024/03]
15.12.2023Change - extension statespublished on 17.01.2024  [2024/03]
Applicant(s)For all designated states
ZBiotics Company
181 2nd St.
San Francisco, CA 94105 / US
[2023/37]
Former [2023/33]For all designated states
Zbiotics Company
845 Market Street, Suite 450
San Francisco, CA 94103 / US
Inventor(s)01 / ABBOTT, Zachary D.
San Francisco, CA 94103 / US
02 / OLIVER, John William Kidder
San Francisco, CA 94103 / US
 [2023/33]
Representative(s)Patent Boutique LLP
10A Printing House Yard
Hackney Road
London E2 7PR / GB
[2023/33]
Application number, filing date21878541.807.10.2021
[2023/33]
WO2021US53983
Priority number, dateUS202063089334P08.10.2020         Original published format: US 202063089334 P
[2023/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022076693
Date:14.04.2022
Language:EN
[2022/15]
Type: A1 Application with search report 
No.:EP4225338
Date:16.08.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 14.04.2022 takes the place of the publication of the European patent application.
[2023/33]
Search report(s)International search report - published on:US14.04.2022
ClassificationIPC:A61K35/74, A61K35/741, A61K35/744, A61K35/745, A61P1/00, C12N1/15
[2023/33]
CPC:
C12N15/75 (EP,GB,KR,US); A61K38/47 (EP,GB,KR,US); A61K38/45 (US);
A61K35/742 (US); A61K35/744 (US); A61K35/745 (US);
A61K35/747 (US); A61P1/00 (EP,GB,KR); C12N1/20 (US);
C12N9/1055 (US); C12N9/90 (US); C12Y204/0101 (US);
C12Y504/99011 (US); C12N2800/101 (US); C12R2001/125 (EP,GB,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/33]
TitleGerman:GENTECHNISCH HERGESTELLTE PROBIOTIKA ZUR EXPRESSION FASERSYNTHETISIERENDER ENZYME IN DARM[2023/33]
English:ENGINEERED PROBIOTICS FOR EXPRESSION OF FIBER-SYNTHESIZING ENZYMES IN GUT[2023/33]
French:PROBIOTIQUES MODIFIÉS POUR L'EXPRESSION D'ENZYMES DE SYNTHÈSE DE FIBRES DANS LE TUBE DIGESTIF[2023/33]
Entry into regional phase02.05.2023National basic fee paid 
02.05.2023Search fee paid 
02.05.2023Designation fee(s) paid 
02.05.2023Examination fee paid 
Examination procedure02.05.2023Examination requested  [2023/33]
23.11.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.10.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9218631  (WEYERHAEUSER CO [US]) [A] 1-6, 29-31,51-56, 69-71 * entire document *;
 [A]DE10106163  (SUEDZUCKER AG [DE]) [A] 1-6, 29-31, 51-56, 69-71 * entire document *;
 [X]US2017267981  (KRALJ SLAVKO [NL], et al) [X] 1-6, 29-31,51-56, 69-71 * entire document *;
 [A]US2019076489  (ABBOTT ZACHARY [US]) [A] 1-6, 29-31, 51-56, 69-71* entire document *;
 [A]  - BAI et al., "Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice", Microbial Cell Factories, (20200425), vol. 19, no. 94, pages 1 - 13, XP055870672 [A] 1-6, 29-31, 51-56, 69-71 * . entire document *

DOI:   http://dx.doi.org/10.1186/s12934-020-01350-z
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.